HomeCompareMBII vs PLD

MBII vs PLD: Dividend Comparison 2026

MBII yields 250.60% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MBII wins by $461.97M in total portfolio value
10 years
MBII
MBII
● Live price
250.60%
Share price
$0.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$467.88M
Annual income
$262,117,387.00
Full MBII calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — MBII vs PLD

📍 MBII pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMBIIPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MBII + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MBII pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MBII
Annual income on $10K today (after 15% tax)
$21,300.59/yr
After 10yr DRIP, annual income (after tax)
$222,799,778.95/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, MBII beats the other by $218,761,662.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MBII + PLD for your $10,000?

MBII: 50%PLD: 50%
100% PLD50/50100% MBII
Portfolio after 10yr
$236.89M
Annual income
$133,434,056.09/yr
Blended yield
56.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

MBII
Analyst Ratings
5
Buy
3
Hold
Consensus: Buy
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MBII buys
0
PLD buys
0
No recent congressional trades found for MBII or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMBIIPLD
Forward yield250.60%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$467.88M$5.91M
Annual income after 10y$262,117,387.00$4,750,725.19
Total dividends collected$445.94M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: MBII vs PLD ($10,000, DRIP)

YearMBII PortfolioMBII Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$35,760$25,059.52$11,241$540.96+$24.5KMBII
2$122,012$83,749.18$13,019$991.13+$109.0KMBII
3$397,612$267,058.97$15,801$1,870.97+$381.8KMBII
4$1,238,800$813,355.61$20,609$3,701.21+$1.22MMBII
5$3,693,827$2,368,311.37$29,919$7,867.97+$3.66MMBII
6$10,552,190$6,599,794.32$50,631$18,617.74+$10.50MMBII
7$28,911,115$17,620,272.02$105,528$51,352.20+$28.81MMBII
8$76,053,022$45,118,129.07$287,364$174,449.42+$75.77MMBII
9$192,299,052$110,922,318.76$1,081,760$774,280.77+$191.22MMBII
10$467,877,373$262,117,387.00$5,908,209$4,750,725.19+$461.97MMBII

MBII vs PLD: Complete Analysis 2026

MBIIStock

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.

Full MBII Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this MBII vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MBII vs SCHDMBII vs JEPIMBII vs OMBII vs KOMBII vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.